secwatch.observer — SEC 8-K summary
======================================

Issuer:     PROCEPT BioRobotics Corp (PRCT)
CIK:        0001588978
Form:       8-K
Filed at:   2026-10-02T20:46:33+00:00
Accession:  0001628280-26-064586
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02, 9.01
LLM model:  deepseek-v4.1-flash:cloud@v2

PROCEPT BioRobotics appoints Dr. Michael Mack to board, increasing size from nine to ten directors
--------------------------------------------------------------------------------

- The board approved increasing its size from nine to ten members and appointed Dr. Michael Mack as a Class II director, effective October 2, 2026.
- Dr. Mack is an independent director, and his initial term will expire at the company's 2029 annual meeting of stockholders.
- Mack is a cardiac surgeon in Dallas since 1982 who is board-certified in internal medicine, general surgery and thoracic surgery and has more than 1,100 peer-reviewed publications.
- He will be compensated consistent with other non-employee directors and will enter the company's standard director and officer indemnification and advancement agreement.
- No arrangements or understandings with other persons and no related-party transactions involving Dr. Mack were disclosed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1588978/000162828026064586/0001628280-26-064586-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1588978/000162828026064586/prct-20261002.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-064586

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer